Susquehanna International Group’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,084
Closed -$22.6K 11368
2020
Q1
$15K Sell
18,084
-9,629
-35% -$10.5K ﹤0.01% 9997
2019
Q4
$28K Buy
+27,713
New +$21.6K ﹤0.01% 9452
2019
Q3
Sell
-85,767
Closed -$393K 11131
2019
Q2
$688K Buy
85,767
+34,318
+67% +$231K ﹤0.01% 6554
2019
Q1
$280K Buy
+51,449
New +$221K ﹤0.01% 7333
2018
Q4
Sell
-19,901
Closed -$121K 10403
2018
Q3
$175K Buy
19,901
+3,815
+24% +$36.5K ﹤0.01% 8320
2018
Q2
$156K Buy
+16,086
New +$148K ﹤0.01% 8817
2018
Q1
Sell
-20,694
Closed -$146K 10569
2017
Q4
$146K Buy
+20,694
New +$121K ﹤0.01% 8506

Other funds holding NTRP

Susquehanna International Group's NTRP Position: Q2 2020 in Review

Susquehanna International Group sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 18,084 shares — an estimated $22.6K sold.

Susquehanna International Group first reported a position in NTRP in Q4 2017 and held it in 7 quarters. The position peaked at $688K in Q2 2019. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Susquehanna International Group reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 18,084 Neurotrope, Inc. Common shares in Q2 2020, an estimated $22.6K.
  • Susquehanna International Group first reported a position in Neurotrope, Inc. Common in Q4 2017 and held it in 7 quarters.
  • Susquehanna International Group's Neurotrope, Inc. Common position peaked at $688K in Q2 2019.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.